APA (7th ed.) Citation

Karashima, T., Komatsu, T., Yamamoto, S., Atagi, K., Hashida, H., Fukuhara, H., . . . Inoue, K. (2025). Transcutaneous Imiquimod Combined With Anti‐Programmed Cell Death‐1 Monoclonal Antibody Extends the Survival of Mice Bearing Renal Cell Carcinoma. Cancer Medicine, 14(10), . https://doi.org/10.1002/cam4.70966

Chicago Style (17th ed.) Citation

Karashima, Takashi, et al. "Transcutaneous Imiquimod Combined With Anti‐Programmed Cell Death‐1 Monoclonal Antibody Extends the Survival of Mice Bearing Renal Cell Carcinoma." Cancer Medicine 14, no. 10 (2025). https://doi.org/10.1002/cam4.70966.

MLA (9th ed.) Citation

Karashima, Takashi, et al. "Transcutaneous Imiquimod Combined With Anti‐Programmed Cell Death‐1 Monoclonal Antibody Extends the Survival of Mice Bearing Renal Cell Carcinoma." Cancer Medicine, vol. 14, no. 10, 2025, https://doi.org/10.1002/cam4.70966.